The Valley Desk

NCT06140524 · Interventional trial

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Overall registry status Recruiting

Phase 2

Conditions Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov